Rising Biosciences (Rising Biosciences) EV-to-Revenue : (As of Jun. 15, 2024)

View and export this data going back to . Start your Free Trial

What is Rising Biosciences EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Rising Biosciences's enterprise value is $0.00 Mil. Rising Biosciences does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Rising Biosciences's EV-to-Revenue at this moment.

The historical rank and industry rank for Rising Biosciences's EV-to-Revenue or its related term are showing as below:

RBII's EV-to-Revenue is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.24
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-15), Rising Biosciences's stock price is $0.0001. Rising Biosciences does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Rising Biosciences's PS Ratio at this moment.

Rising Biosciences EV-to-Revenue Historical Data

The historical data trend for Rising Biosciences's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences EV-to-Revenue Chart

Rising Biosciences Annual Data

Trend

EV-to-Revenue

Rising Biosciences Quarterly Data

EV-to-Revenue

Competitive Comparison of Rising Biosciences's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Rising Biosciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rising Biosciences's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rising Biosciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Rising Biosciences's EV-to-Revenue falls into.

Rising Biosciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Rising Biosciences's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	0.000	/
	=

Rising Biosciences (GREY:RBII) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Rising Biosciences's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.0001	/
	=

Rising Biosciences EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Rising Biosciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Rising Biosciences (Rising Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » EV-to-Revenue

Traded in Other Exchanges

N/A

Address

1180 Cleveland Road, Sandusky, OH, USA, 44870

Website

http://www.risingbiosciences.com

Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.